LOBULAR BREAST CARCINOMA
Clinical trials for LOBULAR BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOBULAR BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for LOBULAR BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for rare breast and stomach cancers
Disease control CompletedThis study tested a combination of two drugs, crizotinib (a tablet) and fulvestrant (an injection), in 33 people with advanced lobular breast cancer that is estrogen-receptor positive. It also tested crizotinib alone in people with diffuse gastric cancer, triple-negative lobular …
Matched conditions: LOBULAR BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
Gene study reveals hidden breast cancer risks in young women
Knowledge-focused CompletedThis study looked at 421 women with lobular breast cancer to see how often they have changes in the CDH1 gene. The goal was to understand if this gene raises breast cancer risk in women without a family history of stomach cancer. Researchers tested blood samples to find gene muta…
Matched conditions: LOBULAR BREAST CARCINOMA
Sponsor: European Institute of Oncology • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC